|
Vaccine Detail
Pseudorabies recombinant vector vaccine encoding gp50 and gII protein |
Vaccine Information |
- Vaccine Name: Pseudorabies recombinant vector vaccine encoding gp50 and gII protein
- Target Pathogen: Pseudorabies virus
- Target Disease: Aujeszky's disease
- Vaccine Ontology ID: VO_0004156
- Type: Recombinant vector vaccine
- Status: Licensed
- gp50
gene engineering:
- Type: Recombinant vector construction
- Description:
- Detailed Gene Information: Click Here.
- GII
gene engineering:
- Type: Recombinant vector construction
- Description:
- Detailed Gene Information: Click Here.
- Immunization Route: Intramuscular injection (i.m.)
|
Host Response |
Pig Response
- Vaccination Protocol: 4-6 wk old male pigs from a PRV negative herd were vaccinated intramuscularly with two injections in the thigh of 10^7 CCID50 of NYVAC/gp50gpII 4 weeks apart. The control group was not vaccinated (Brockmeier and Mengeling, 1996).
- Challenge Protocol: Challenge consisted of administering 10^8 PFU of Indiana-Funkhauser strain of PRV oranasally, 4 weeks after the 2nd immunization (Brockmeier and Mengeling, 1996).
- Efficacy: Vaccinated pigs were protected from PRV challenge (Brockmeier and Mengeling, 1996).
|
References |
Brockmeier and Mengeling, 1996: Brockmeier SL, Mengeling WL. Comparison of the protective response induced by NYVAC vaccinia recombinants expressing either gp50 or gII and gp50 of pseudorabies virus. Canadian journal of veterinary research = Revue canadienne de recherche veterinaire. 1996; 60(4); 315-317. [PubMed: 8904669].
|
|